Shenzhen Bioeasy Biotechnology Co (SZSE:300942) EV-to-Revenue : 9.73 (As of Jun. 23, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Shenzhen Bioeasy Biotechnology Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Shenzhen Bioeasy Biotechnology Co's enterprise value is ¥2,235.9 Mil. Shenzhen Bioeasy Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥229.9 Mil. Therefore, Shenzhen Bioeasy Biotechnology Co's EV-to-Revenue for today is 9.73.

The historical rank and industry rank for Shenzhen Bioeasy Biotechnology Co's EV-to-Revenue or its related term are showing as below:

SZSE:300942' s EV-to-Revenue Range Over the Past 10 Years
Min: 8.23 Med: 15.08 Max: 39.88
Current: 9.73

During the past 8 years, the highest EV-to-Revenue of Shenzhen Bioeasy Biotechnology Co was 39.88. The lowest was 8.23. And the median was 15.08.

SZSE:300942's EV-to-Revenue is ranked worse than
55.32% of 1034 companies
in the Biotechnology industry
Industry Median: 7.69 vs SZSE:300942: 9.73

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-23), Shenzhen Bioeasy Biotechnology Co's stock price is ¥5.74. Shenzhen Bioeasy Biotechnology Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.58. Therefore, Shenzhen Bioeasy Biotechnology Co's PS Ratio for today is 9.83.

Shenzhen Bioeasy Biotechnology Co EV-to-Revenue Historical Data

The historical data trend for Shenzhen Bioeasy Biotechnology Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Bioeasy Biotechnology Co EV-to-Revenue Chart

Shenzhen Bioeasy Biotechnology Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

18.29

9.82

17.51

Shenzhen Bioeasy Biotechnology Co Quarterly Data
	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															14.11	14.99	16.88	17.51	14.41

Competitive Comparison of Shenzhen Bioeasy Biotechnology Co's EV-to-Revenue

For the Biotechnology subindustry, Shenzhen Bioeasy Biotechnology Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shenzhen Bioeasy Biotechnology Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shenzhen Bioeasy Biotechnology Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shenzhen Bioeasy Biotechnology Co's EV-to-Revenue falls into.

Shenzhen Bioeasy Biotechnology Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Shenzhen Bioeasy Biotechnology Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	2235.934	/	229.874
	=	9.73

Shenzhen Bioeasy Biotechnology Co's current Enterprise Value is ¥2,235.9 Mil.
Shenzhen Bioeasy Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥229.9 Mil.

Shenzhen Bioeasy Biotechnology Co (SZSE:300942) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Shenzhen Bioeasy Biotechnology Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	5.74	/	0.584
	=	9.83

Shenzhen Bioeasy Biotechnology Co's share price for today is ¥5.74.
Shenzhen Bioeasy Biotechnology Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.58.

Shenzhen Bioeasy Biotechnology Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shenzhen Bioeasy Biotechnology Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Bioeasy Biotechnology Co (SZSE:300942) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shenzhen Bioeasy Biotechnology Co Ltd (SZSE:300942) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Liuxian 1st Road, Xin'an Street, 101, Yirui Biological Building, Xingdong Community, Bao'an District, Guangdong Province, Shenzhen, CHN, 518101

Website

http://www.bioeasy.com

Shenzhen Bioeasy Biotechnology Co Ltd is dedicated towards food and drug safety, clinical diagnosis, public safety and other fields. It produces and sells clinical diagnosis products. It develops testing products for nine areas closely related to people's lives which include food safety, agricultural product safety, dairy product safety, meat safety, aquatic product safety, honey safety, clinical diagnosis, drug safety, and public safety.

Executives

Fu Hui

Directors, executives

Shenzhen Bioeasy Biotechnology Co (SZSE:300942) Headlines

No Headlines